Abstract: The compounds have the structure 2-(2-amino or alkyl-amido-2-desoxy-3-O-D-glucopyranosyl)-alkanyl-dipeptide, possibly substituted on the saccharide residue the amino acid residue at the end of the peptide chain being a D-glutamyl residue whose .alpha.-carboxy function is esterified and .gamma.-carboxyl function amidated. The compounds are valuable as immunological medicaments.
November 7, 1985
Date of Patent:
September 15, 1987
Agence Nationale de Valorisation de la Rechersche
Pierre Lefrancier, Monique Parant, Francoise Audibert, Louis Chedid, Jean Choay, Edgar Lederer